AbbVie拟109亿美元现金收购Apogee
2026-06-22 13:36:26
艾伯维(AbbVie Inc.)同意以109亿美元现金收购Apogee Therapeutics Inc.，以强化其抗炎药物产品组合，应对其畅销药Skyrizi面临的竞争加剧。据彭博社报道，
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
U.S. Treasury Secretary Bessent Says Iran Committed to Open Passage Through Strait of HormuzNext article：
卡塔尔称国内天然气爆炸不影响LNG出口
